Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
Key | |
---|---|
Module Score | Databases |
Where interaction is observed in another database a link is provided: |
Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
---|---|---|---|---|---|---|---|---|---|
RPS6KA2 | NR4A2 | NR4A2, NOT, NURR1, TINUR: Orphan nuclear receptor NR4A2 | 1.67E3 | Evidence | |||||
RPS6KA2 | RPS6KA3 | RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 | 196.0 | Evidence | |||||
RPS6KA2 | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 61.60 | Evidence | |||||
RPS6KA2 | DUSP1 | DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 | 33.90 | Evidence | |||||
RPS6KA2 | MAPK3 | MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 | 31.10 | Evidence | |||||
RPS6KA2 | EEF1B2 | EEF1B2, EEF1B, EF1B: Elongation factor 1-beta | 25.00 | Evidence | |||||
RPS6KA2 | SNCG | SNCG, BCSG1, PERSYN, PRSN: Gamma-synuclein | 22.90 | Evidence | |||||
RPS6KA2 | RAF1 | RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase | 20.50 | Evidence | |||||
RPS6KA2 | DUSP16 | DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 | 20.50 | Evidence | |||||
RPS6KA2 | DUSP6 | DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 | 20.50 | Evidence | |||||
RPS6KA2 | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 20.50 | Evidence | |||||
RPS6KA2 | IRS1 | IRS1: Insulin receptor substrate 1 | 19.70 | Evidence | |||||
RPS6KA2 | DUSP3 | DUSP3, VHR: Dual specificity protein phosphatase 3 | 19.70 | Evidence | |||||
RPS6KA2 | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 19.70 | Evidence | |||||
RPS6KA2 | GAB1 | GAB1: GRB2-associated-binding protein 1 | 19.70 | Evidence | |||||
RPS6KA2 | PLCB1 | PLCB1, KIAA0581: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta- | 17.60 | Evidence | |||||
RPS6KA2 | PDPK1 | PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 | 17.60 | Evidence | |||||
RPS6KA2 | LYN | LYN: Tyrosine-protein kinase Lyn | 17.60 | Evidence | |||||
RPS6KA2 | STMN1 | STMN1, LAP18, OP18: Stathmin | 17.60 | Evidence | |||||
RPS6KA2 | SYK | SYK: Tyrosine-protein kinase SYK | 17.60 | Evidence | |||||
RPS6KA2 | BRAF | BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase | 17.60 | Evidence | |||||
RPS6KA2 | PRKCZ | PRKCZ, PKC2: Protein kinase C zeta type | 17.60 | Evidence | |||||
RPS6KA2 | ADRBK1 | ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 | 17.60 | Evidence | |||||
RPS6KA2 | SPTBN1 | SPTBN1, SPTB2: Spectrin beta chain, brain 1 | 17.60 | Evidence | |||||
RPS6KA2 | STMN2 | STMN2, SCG10, SCGN10: Stathmin-2 | 17.60 | Evidence | |||||
RPS6KA2 | STAT3 | 17.60 | Evidence | ||||||
RPS6KA2 | PTPRR | PTPRR, ECPTP, PTPRQ: Receptor-type tyrosine-protein phosphatase R precursor | 13.00 | Evidence | |||||
RPS6KA2 | PTPRC | PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ | 13.00 | Evidence | |||||
RPS6KA2 | PTPRE | PTPRE: Receptor-type tyrosine-protein phosphatase epsilon precursor | 13.00 | Evidence | |||||
RPS6KA2 | HSF1 | HSF1, HSTF1: Heat shock factor protein 1 | 10.30 | Evidence | |||||
RPS6KA2 | JUN | JUN: Transcription factor AP-1 | 10.30 | Evidence | |||||
RPS6KA2 | MAPK8 | MAPK8, JNK1, PRKM8: Mitogen-activated protein kinase 8 | 9.96 | Evidence | |||||
RPS6KA2 | RAB4A | N/A | 9.96 | Evidence | |||||
RPS6KA2 | CASP9 | CASP9, MCH6: Caspase-9 precursor | 9.96 | Evidence | |||||
RPS6KA2 | PEA15 | PEA15: Astrocytic phosphoprotein PEA-15 | 9.96 | Evidence | |||||
RPS6KA2 | MGMT | MGMT: Methylated-DNA--protein-cysteine methyltransferase | 9.96 | Evidence | |||||
RPS6KA2 | HSPB8 | HSPB8, CRYAC, PP1629, E2IG1, HSP22: Heat shock protein beta-8 | 8.92 | Evidence | |||||
RPS6KA2 | ETS1 | ETS1, EWSR2: Protein C-ets-1 | 8.92 | Evidence | |||||
RPS6KA2 | DAPK1 | DAPK1, DAPK: Death-associated protein kinase 1 | 8.92 | Evidence | |||||
RPS6KA2 | ELK1 | ELK1: ETS domain-containing protein Elk-1 | 8.92 | Evidence | |||||
RPS6KA2 | IRAK1 | IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 | 8.92 | Evidence | |||||
RPS6KA2 | JUND | JUND: Transcription factor jun-D | 8.92 | Evidence | |||||
RPS6KA2 | CEBPB | CEBPB, TCF5, PP9092: CCAAT/enhancer-binding protein beta | 8.92 | Evidence | |||||
RPS6KA2 | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 8.92 | Evidence | |||||
RPS6KA2 | PTPRA | N/A | 7.14 | Evidence | |||||
RPS6KA2 | GJA1 | GJA1, GJAL: Gap junction alpha-1 protein | 7.14 | Evidence | |||||
RPS6KA2 | TH | TH, TYH: Tyrosine 3-monooxygenase | 6.39 | Evidence | |||||
RPS6KA2 | MINK1 | MAP4K6, MINK1, MINK: Misshapen-like kinase 1 | 6.24 | Evidence | |||||
RPS6KA2 | AMPH | AMPH, AMPH1: Amphiphysin | 6.24 | Evidence | |||||
RPS6KA2 | EPOR | EPOR: Erythropoietin receptor precursor | 5.87 | Evidence | |||||
RPS6KA2 | NGFR | NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor | 5.87 | Evidence | |||||
RPS6KA2 | CD44 | N/A | 5.87 | Evidence | |||||
RPS6KA2 | TUBB | TUBB, TUBB5, OK/SW-cl.56: Tubulin beta chain | 5.59 | Evidence | |||||
RPS6KA2 | ATP1A1 | ATP1A1: Sodium/potassium-transporting ATPase subunit alpha-1 precursor | 5.26 | Evidence | |||||
RPS6KA2 | ADAM33 | ADAM33, UNQ873/PRO1891: ADAM 33 precursor | 5.26 | Evidence | |||||
RPS6KA2 | C1QBP | C1QBP, GC1QBP, HABP1, SF2P32: Complement component 1 Q subcomponent-binding prot | 4.19 | Evidence | |||||
RPS6KA2 | BCL2 | BCL2: Apoptosis regulator Bcl-2 | 4.03 | Evidence | |||||
RPS6KA2 | KRT8 | KRT8, CYK8: Keratin, type II cytoskeletal 8 | 4.03 | Evidence | |||||
RPS6KA2 | DUSP10 | DUSP10, MKP5: Dual specificity protein phosphatase 10 | 3.70 | Evidence | |||||
RPS6KA2 | OSBPL6 | OSBPL6, ORP6: Oxysterol-binding protein-related protein 6 | 3.70 | Evidence | |||||
RPS6KA2 | TOB1 | TOB1, TOB, TROB1: Protein Tob1 | 3.63 | Evidence | |||||
RPS6KA2 | BTG1 | BTG1: Protein BTG1 | 3.63 | Evidence | |||||
RPS6KA2 | TAL2 | TAL2: T-cell acute lymphocytic leukemia protein 2 | 3.47 | Evidence | |||||
RPS6KA2 | MKNK1 | MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 | 3.47 | Evidence | |||||
RPS6KA2 | RPS6KA5 | RPS6KA5, MSK1: Ribosomal protein S6 kinase alpha-5 | 3.47 | Evidence | |||||
RPS6KA2 | MAP2K2 | MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki | 3.47 | Evidence | |||||
RPS6KA2 | MAP3K14 | MAP3K14, NIK: Mitogen-activated protein kinase kinase kinase 14 | 3.34 | Evidence | |||||
RPS6KA2 | NFIA | NFIA, RP5-902P15.1-003, hCG_2032260: Nuclear factor I/A | 3.34 | Evidence | |||||
RPS6KA2 | PPARA | PPARA, NR1C1, PPAR: Peroxisome proliferator-activated receptor alpha | 3.34 | Evidence | |||||
RPS6KA2 | RAVER1 | RAVER1, KIAA1978: Ribonucleoprotein PTB-binding 1 | 3.34 | Evidence | |||||
RPS6KA2 | TOP2B | N/A | 3.34 | Evidence | |||||
RPS6KA2 | UBTF | UBTF, UBF, UBF1: Nucleolar transcription factor 1 | 3.34 | Evidence | |||||
RPS6KA2 | PTPN7 | N/A | 3.34 | Evidence | |||||
RPS6KA2 | ESR1 | ESR1, ESR, NR3A1: Estrogen receptor | 3.34 | Evidence | |||||
RPS6KA2 | DUSP4 | DUSP4, MKP2, VH2: Dual specificity protein phosphatase 4 | 3.31 | Evidence | |||||
RPS6KA2 | DUSP2 | DUSP2, PAC1: Dual specificity protein phosphatase 2 | 3.31 | Evidence | |||||
RPS6KA2 | ARHGEF1 | ARHGEF1: Rho guanine nucleotide exchange factor 1 | 3.18 | Evidence | |||||
RPS6KA2 | HDAC4 | HDAC4, KIAA0288: Histone deacetylase 4 | 2.99 | Evidence | |||||
RPS6KA2 | MAP2K1 | MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 | 2.99 | Evidence | |||||
RPS6KA2 | SORBS3 | SORBS3, SCAM1: Vinexin | 2.99 | Evidence | |||||
RPS6KA2 | TP53 | TP53, P53: Cellular tumor antigen p53 | 2.99 | Evidence | |||||
RPS6KA2 | FKBP1A | FKBP1A, FKBP1, FKBP12: FK506-binding protein 1A | 2.99 | Evidence | |||||
RPS6KA2 | MAP2K3 | N/A | 2.99 | Evidence | |||||
RPS6KA2 | RPS6KA4 | RPS6KA4, MSK2: Ribosomal protein S6 kinase alpha-4 | 2.99 | Evidence | |||||
RPS6KA2 | TCF3 | TCF3, E2A, ITF1: Transcription factor E2-alpha | 2.99 | Evidence | |||||
RPS6KA2 | RPS6KA1 | RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 | 2.99 | Evidence | |||||
RPS6KA2 | TAL1 | TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 | 2.99 | Evidence | |||||
RPS6KA2 | HIF1A | HIF1A, MOP1: Hypoxia-inducible factor 1 alpha | 2.99 | Evidence | |||||
RPS6KA2 | MRE11A | MRE11A, HNGS1, MRE11: Double-strand break repair protein MRE11A | 2.99 | Evidence | |||||
RPS6KA2 | PTPN11 | N/A | 2.99 | Evidence | |||||
RPS6KA2 | SMAD2 | SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 | 2.99 | Evidence | |||||
RPS6KA2 | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 2.93 | Evidence | |||||
RPS6KA2 | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 2.93 | Evidence |